Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

Circulation: Arrhythmia and Electrophysiology - United States
doi 10.1161/circep.112.972869
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

New Score for Assessing Bleeding Risk in Patients With Atrial Fibrillation Treated With NOACs

Open Heart
Cardiovascular MedicineCardiology
2018English

Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI

New England Journal of Medicine
Medicine
2016English

Suboptimal Oral Anticoagulant Treatment Among Chinese Non-Valvular Atrial Fibrillation Patients: The Nanchang Atrial Fibrillation Project

Archives of Medical Science
Medicine
2016English

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies

Frontiers in Medicine
Medicine
2020English

Nonsteroidal Anti-Inflammatory Drugs and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

Expert Review of Cardiovascular Therapy
Internal MedicineMedicineCardiovascular MedicineCardiology
2015English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Risk Factors and Prevention of Dabigatran-Related Gastrointestinal Bleeding in Patients With Atrial Fibrillation

Journal of Arrhythmia
Cardiovascular MedicineCardiology
2017English

Role of Atrial Fibrillation Burden in Assessing Thromboembolic Risk

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2014English

Atrial Fibrillation: Risk Assessment

The Southwest Respiratory and Critical Care Chronicles
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy